Baseline Characteristics of 543 595 Israeli Individuals With Incident Diabetes, Followed Up From 2009 to 2017 for Pancreatic Cancer Incidence (3 290 439 Person-Years) According to Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Ever-Users and Basal Insulin Ever-Users. This evidence concerns the gene INS and familial pancreatic carcinoma.